HomeCompareKOSK vs JNJ

KOSK vs JNJ: Dividend Comparison 2026

KOSK yields 26666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KOSK wins by $915008218858322657280.00M in total portfolio value
10 years
KOSK
KOSK
● Live price
26666.67%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$915008218858322657280.00M
Annual income
$908,307,797,917,658,400,000,000,000.00
Full KOSK calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — KOSK vs JNJ

📍 KOSK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKOSKJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KOSK + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KOSK pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KOSK
Annual income on $10K today (after 15% tax)
$2,266,666.67/yr
After 10yr DRIP, annual income (after tax)
$772,061,628,230,009,600,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, KOSK beats the other by $772,061,628,230,009,600,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KOSK + JNJ for your $10,000?

KOSK: 50%JNJ: 50%
100% JNJ50/50100% KOSK
Portfolio after 10yr
$457504109429161328640.00M
Annual income
$454,153,898,958,829,200,000,000,000.00/yr
Blended yield
99.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KOSK
No analyst data
Altman Z
-12.2
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KOSK buys
0
JNJ buys
0
No recent congressional trades found for KOSK or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKOSKJNJ
Forward yield26666.67%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$915008218858322657280.00M$20.0K
Annual income after 10y$908,307,797,917,658,400,000,000,000.00$827.78
Total dividends collected$914567051678776164352.00M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KOSK vs JNJ ($10,000, DRIP)

YearKOSK PortfolioKOSK Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,677,367$2,666,666.67$10,676$355.77+$2.67MKOSK
2$670,121,272$667,256,490.13$11,407$389.39+$670.11MKOSK
3$156,799,662,298$156,082,632,536.95$12,198$426.53+$156799.65MKOSK
4$34,299,837,353,716$34,132,061,715,056.25$13,056$467.62+$34299837.34MKOSK
5$7,014,615,943,610,743$6,977,915,117,642,268.00$13,987$513.12+$7014615943.60MKOSK
6$1,341,192,098,307,730,000$1,333,686,459,248,066,600.00$14,998$563.56+$1341192098307.71MKOSK
7$239,753,188,972,257,800,000$238,318,113,427,068,550,000.00$16,098$619.52+$239753188972257.81MKOSK
8$40,071,532,325,128,600,000,000$39,814,996,412,928,290,000,000.00$17,295$681.69+$40071532325128600.00MKOSK
9$6,262,075,645,480,441,000,000,000$6,219,199,105,892,554,000,000,000.00$18,599$750.82+$6262075645480440832.00MKOSK
10$915,008,218,858,322,600,000,000,000$908,307,797,917,658,400,000,000,000.00$20,022$827.78+$915008218858322657280.00MKOSK

KOSK vs JNJ: Complete Analysis 2026

KOSKStock

Metawells Oil & Gas Inc. is a holdings company founded in the State of Nevada and engaged in two sectors, the energy sector and the sector of technology. The Company is set to forge strategic collaborations and develop both business segments to accelerate the company growth.

Full KOSK Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this KOSK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KOSK vs SCHDKOSK vs JEPIKOSK vs OKOSK vs KOKOSK vs MAINKOSK vs ABBVKOSK vs MRKKOSK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.